Sysmex (OTCMKTS:SSMXY) Hits New 12-Month High – Time to Buy?

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s share price reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as $13.01 and last traded at $13.01, with a volume of 6,074 shares traded. The stock had previously closed at $12.1850.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Sysmex Trading Up 3.4%

The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53. The company’s 50 day moving average is $11.94 and its two-hundred day moving average is $9.98. The firm has a market cap of $7.82 billion, a P/E ratio of 30.62 and a beta of 1.20.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.02. The firm had revenue of $825.85 million for the quarter, compared to analyst estimates of $741.67 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. On average, sell-side analysts predict that Sysmex Corporation ADR will post 0.41 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes clinical laboratory instruments, reagents and related information systems. Its products are used by hospitals, diagnostic laboratories and other healthcare providers to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology analyzers, which help laboratories evaluate blood cells and identify conditions such as anemia and leukemia.